CPL Biologicals , a joint venture of Cadila Pharmaceuticals Ltd. and Novavax, Inc. , today announced that it has completed construction of its vaccine facility in Dholka, India and will commence equipment and installation validation this month so that the facility conforms to global standards for production of vaccines for human use.
